Pendulum Akkermansia, made by Pendulum Therapeutics, is a single-strain capsule of live Akkermansia muciniphila: 100 million AFU per serving with chicory inulin, at $54 a month on subscription. No published randomized trial has tested this exact product, and its gut-lining claims are footnoted on its own page as "based on preclinical studies"[1].
The human trials people quote tested something else: a five-strain Pendulum formula in type 2 diabetes[2], or other companies' strains at roughly 100 times the dose, often pasteurized rather than live[3][4]. This review sets out what the capsule contains, what each trial found, what it costs per day, and who should skip it.
Is Pendulum Akkermansia worth it? The bottom line
Pendulum makes a real live product, and its A. muciniphila powder passed a 90-day rat safety study[5].
But the evidence for taking this capsule is thin. The best human results for A. muciniphila come from pasteurized cells at 10 to 30 billion a day[3][4], and recent trials found benefits mostly in people who started with little Akkermansia[6].
So, are Pendulum probiotics good, and is Akkermansia worth taking? Pendulum Akkermansia is a plausible, low-risk experiment if you can afford about $1.60 to $2.50 a day and have no condition that calls for caution. It is not a proven treatment for gut permeability, weight or blood sugar.
How we reviewed this
We did not test the product hands-on, and we have no affiliate relationship with Pendulum. For this review we:
- retrieved Pendulum's product page in October 2026 for ingredients, dose, directions, storage and prices[1];
- searched PubMed for every randomized trial of A. muciniphila in people and read the five most relevant, including Pendulum's own[2];
- read Pendulum's published toxicology study[5] and the European safety opinion on pasteurized A. muciniphila[7];
- checked who funded each study, because most A. muciniphila trials are run by the companies that sell it.
Prices change often. Treat the figures below as a snapshot from the date we checked.
What is in Pendulum Akkermansia?
Each capsule contains one live strain plus a prebiotic fiber and standard capsule fillers. Pendulum describes it as a single-strain probiotic[1].
| Ingredient | Amount listed | What it does |
|---|---|---|
| Akkermansia muciniphila (live) | 100 million AFU | The active probiotic strain |
| Chicory inulin | Not stated | Prebiotic fiber |
| Microcrystalline cellulose, L-leucine, silica | Not stated | Fillers and flow agents |
| Hypromellose | Capsule shell | Vegetarian capsule |
Source: Pendulum product page, retrieved October 2026[1].
Note the unit: the dose is labelled in AFU (active fluorescent units), not in the cell counts the trials below report[1][3]. Our guide to next-generation probiotics you can actually buy explains how AFU is counted.
The directions are one capsule a day with food, ideally a meal with fiber, and Pendulum lists the product as FSA/HSA eligible through a third-party service[1].
How much does it cost per day?
| Purchase option (October 2026) | Price | Cost per day |
|---|---|---|
| One-time, 1-month supply | $75 | $2.50 |
| Subscription, 1 month | $54 every 30 days | $1.80 |
| Subscription, 3 months | $145 every 90 days | $1.61 |
| First subscription order (welcome offer) | $43.20 for 1 month | $1.44 |
Prices from Pendulum's product page[1].
Has Pendulum Akkermansia been tested in people?
Not as a finished product in a published controlled trial. We found no randomized trial of the single-strain Akkermansia capsule in PubMed.
Here is what Pendulum's page actually rests on:
- Gut-lining claims. "Fortifies the gut lining" and "reduces gut permeability" are marked with an asterisk that reads "based on preclinical studies"[1]. Preclinical means lab or animal work.
- A consumer survey. Pendulum reports that of 172 people using the product for 12 weeks, 82% reported better bowel movements and 71% less gas and bloating[1]. This was self-reported, with no placebo group, so it cannot separate the capsule's effect from expectation.
- A safety study in rats. Pendulum-funded toxicology work found no adverse effects in rats given live A. muciniphila powder for 90 days at up to about 1.64 × 1011 units per kg of body weight a day, and no bacteria escaping the gut into the liver, lymph nodes or blood[5].
What about Pendulum Glucose Control?
Pendulum's only published randomized, double-blind trial tested a five-strain formula called WBF-011. It combined inulin with A. muciniphila, Clostridium beijerinckii, Clostridium butyricum, Bifidobacterium infantis and Anaerobutyricum hallii, taken twice a day for 12 weeks[2].
In 76 adults with type 2 diabetes, WBF-011 lowered the after-meal glucose curve by 36.1 mg/dL over 180 minutes versus placebo, with p=0.0500, right at the significance line[2]. A1c fell 0.6 points more than placebo. Every author was a Pendulum employee or shareholder, and the authors themselves flagged the small sample and higher placebo dropout as limits[2].
That trial does not tell you what one strain does alone. Pendulum's own page points people with type 2 diabetes who want lower A1C to Glucose Control, not to Akkermansia[1]. We cover that product's strain list in our next-generation probiotics guide.
What do Akkermansia trials actually show?
The human trials are small, short and mostly company-run, and their results depend on the form, the dose and the person. None used Pendulum's single-strain capsule.
| Trial | People | Form and daily dose | Main result | Funding or authors |
|---|---|---|---|---|
| Depommier 2019 | 32 completers, overweight or obese, insulin resistant; 3 months | Live or pasteurized, 10 billion cells | Pasteurized: insulin sensitivity +28.6%, cholesterol −8.7% vs placebo; weight change not significant | Patent holders; company co-founders |
| Perraudeau 2020 | 76 with type 2 diabetes; 12 weeks | Five-strain live formula with inulin (WBF-011) | After-meal glucose −36.1 mg/dL/180 min, p=0.0500 | All Pendulum employees |
| Zhang 2025 | 58 with overweight or obesity and type 2 diabetes; 12 weeks | Strain AKK-WST01 | No overall difference vs placebo; benefits only in low-baseline group | No competing interests declared |
| Suenaert 2026 | 142 with metabolic syndrome; 4 months | Pasteurized MucT, 30 billion cells | Primary insulin-sensitivity endpoint missed; gains in low-baseline group | Company employees and consultants |
| Mount 2026 | 90 with overweight or obesity after a diet; 24-week maintenance | Pasteurized MucT | Regained 1.2 kg vs 3.2 kg on placebo | Company co-founder and employees |
Sources: Depommier 2019[3], Perraudeau 2020[2], Zhang 2025[6], Suenaert 2026[4], Mount 2026[8].
Live or pasteurized: which form has the evidence?
Pasteurized (heat-killed) A. muciniphila has the stronger human record, which surprises many buyers. In the first human trial, live and pasteurized cells were both safe, but the significant metabolic improvements came from the pasteurized arm[3]. The two larger 2026 trials also used a pasteurized strain[4][8].
European regulators assessed pasteurized A. muciniphila as safe at 34 billion cells a day for adults, provided live cells are essentially absent[7]. That opinion does not cover live products like Pendulum's.
So "live" is not automatically better; it is a different product with fewer clinical trials behind it.
The dose gap
Pendulum's capsule lists 100 million AFU. The pasteurized trials used 10 billion and 30 billion cells a day, about 100 and 300 times more by raw count[3][4].
The units are not identical, so the comparison is approximate. Still, no trial has shown that 100 million units of any A. muciniphila changes a health outcome.
Pendulum says each serving helps replenish Akkermansia levels[1]. Whether a small live dose can grow enough in the gut to match a large pasteurized one has not been tested.
Results depend on how much you already have
Two recent trials point the same way. In 58 people with type 2 diabetes, the supplement colonized well and lowered weight, fat mass and HbA1c only in those who started with little A. muciniphila; people with high levels saw poor colonization and no benefit[6]. The 142-person MucT trial missed its main endpoint overall but found improvements in the low-baseline group[4].
This fits older observational work. In 49 adults on a calorie-restricted diet, higher starting levels of A. muciniphila went with lower fasting glucose and a healthier waist-to-hip ratio[9]. The practical point is that most buyers do not know their own level, so they cannot tell whether they are in the group that might respond.
Does Pendulum Akkermansia help with weight loss or GLP-1?
There is no published evidence that Pendulum's single-strain capsule causes weight loss or raises GLP-1 in people. The supporting data come from other forms and from animals.
- Weight. In the first human trial, pasteurized cells cut body weight by 2.27 kg versus placebo, but the difference was not statistically significant[3]. A 2026 trial found less regain after dieting (1.2 kg versus 3.2 kg), again with a pasteurized strain[8]. Neither is evidence for weight loss from Pendulum's product. See our obesity page for the wider microbiome picture.
- GLP-1. In mice on a high-fat diet, a protein secreted by A. muciniphila called P9 was enough to trigger GLP-1 release[10]. In people, the 142-person MucT trial saw a larger GLP-1 rise after a glucose drink, mainly in those with low starting Akkermansia[4].
Our GLP-1 probiotics guide compares these claims across brands. A probiotic is not a substitute for prescribed GLP-1 medicines, and you should not stop or change one on the strength of a supplement.
Is Pendulum Akkermansia safe, and what side effects are reported?
For most healthy adults, the risk appears low, though as a dietary supplement it did not need FDA approval for safety or effectiveness before sale[11]. NIH's Office of Dietary Supplements says probiotics are unlikely to harm healthy people and that side effects are usually minor[12].
What the studies report:
- Digestive complaints. In Pendulum's diabetes trial, diarrhea, nausea and vomiting were reported in 15% on the five-strain formula versus 27% on placebo[2].
- No safety signal at 10 billion cells. Live and pasteurized A. muciniphila were safe and well tolerated over 3 months[3].
- Gas or bloating from the fiber. Chicory inulin mildly increased flatulence and bloating in a controlled study, though native inulin up to 10 g a day was well tolerated[13]. Pendulum does not state how much inulin is in each capsule[1].
- Animal safety. Pendulum's rat study found no toxicity and no genetic damage[5].
Rare serious infections from probiotics have mostly occurred in people who were severely ill or immunocompromised[12]. For a broader look at what to expect in the first weeks, see our guide to probiotic side effects.
Who should not take Akkermansia?
Some groups should skip it or ask a clinician first, because more Akkermansia is not always better. A 2023 review argued that its use should be judged person by person[14].
- People with inflammatory bowel disease. The same review cautions that extra Akkermansia may not help in IBD, in some gut infections, or while the microbiome is rebuilding after antibiotics[14].
- People with PCOS or endometriosis. The authors flag these because of a higher IBD risk[14]. See our PCOS page.
- People with Parkinson's disease or multiple sclerosis. A meta-analysis of 1,703 people found more Akkermansia in Parkinson's disease than in controls[15]. That is an association, not proof of harm, but it is a reason to ask your neurologist.
- People who are immunocompromised or seriously ill, given the rare infection reports[12].
- People who are pregnant or breastfeeding. Pendulum says its product has not been studied in this group[1].
- Anyone on diabetes medicine should tell their clinician before adding it, and should not adjust doses on their own.
Is Pendulum the best Akkermansia supplement?
No brand has been shown to beat another, because there are no head-to-head trials. Pendulum is the best-known live option; the most human trial data belong to a pasteurized strain from a different company[4][8].
If you are comparing products, check four things:
- Form. Live or pasteurized. The pasteurized form has the larger trial base and a European safety opinion[7].
- Dose per day, and whether it is stated in cells, AFU or milligrams.
- A named strain with published human data on that strain, not just on the species.
- Cost per day at the dose the trials used.
Researchers describe A. muciniphila as a model next-generation microbe, but they also note that most of the human evidence is still associative[16].
Some common medicines also shift it: in one study, people with diabetes taking metformin had more A. muciniphila and more short-chain fatty acid producers than people without diabetes[17]. For the biology and food research, see our Akkermansia muciniphila page.
If your goal is general gut health rather than this one microbe, our best probiotics guide covers strains with deeper trial records, and our microbiome supplement roundup compares the wider category. For another product we checked the same way, see our Seed probiotics review.
Disclosure
Biome Guide has no affiliate link, sponsorship or free product from Pendulum. We did not test the capsule ourselves. Every product detail comes from Pendulum's page as retrieved in October 2026, and every health claim comes from the studies cited above.
This article is for general educational purposes and is not medical advice. Product details, ingredients and prices were taken from the manufacturer's website in October 2026 and may have changed. Talk to a qualified healthcare professional before starting Pendulum Akkermansia or any probiotic, particularly if you are pregnant, immunocompromised, taking prescription medication, or managing a diagnosed condition such as diabetes or inflammatory bowel disease.
Frequently Asked Questions
Does Pendulum Akkermansia need to be refrigerated?
Not strictly. Pendulum's product page, retrieved in October 2026, says to store the bottle in a cool, dry place and that refrigeration is best though not required. For travel, it suggests refrigerating the bottle again on arrival. Because the product contains live, oxygen-sensitive bacteria, keeping it cool and tightly closed is the cautious choice.
When should I take Pendulum Akkermansia?
The label directions are one capsule a day with food, ideally a meal that contains fiber. Pendulum does not name a best time of day, and no published study has compared morning with evening dosing for this product. Taking it at the same meal each day mainly helps you remember it.
Can Akkermansia cause constipation?
There is no good evidence that it does. In Pendulum's own 12-week trial of a five-strain formula, the digestive complaints recorded were diarrhea, nausea and vomiting, not constipation, and they were less common on the probiotic (15%) than on placebo (27%). The chicory inulin in the capsule can cause gas or bloating in some people. If your bowel habits change and stay changed, stop and check with a clinician.
Does Akkermansia increase GLP-1?
In mice, a protein secreted by A. muciniphila called P9 triggered GLP-1 release. In people, the clearest signal comes from a 2026 trial of a pasteurized strain (MucT) at 30 billion cells a day, where GLP-1 rose after a glucose drink mainly in participants who started with little Akkermansia. No published trial has measured GLP-1 with Pendulum's single-strain product, so a GLP-1 effect from it is unproven.
How can you increase Akkermansia in your gut without a supplement?
Diet and some medicines are linked to higher levels. In one study, people with diabetes taking metformin had more A. muciniphila than matched people without diabetes. Our Akkermansia muciniphila page covers the food and fiber research. Never start or change a prescription medicine to raise a gut bacterium.
Is Pendulum Akkermansia FDA approved?
No. It is sold as a dietary supplement, and under US law (DSHEA) the FDA is not authorized to approve dietary supplements for safety and effectiveness before they are marketed. The company is responsible for the product's safety and claims. A rat safety study of Pendulum's live A. muciniphila powder exists, but that is not FDA approval.
Can you take Pendulum Akkermansia while pregnant or breastfeeding?
Pendulum states on its product page that its Akkermansia has not been studied in people who are pregnant, planning a pregnancy or breastfeeding, and it asks them to consult a healthcare provider. The European safety assessment of pasteurized A. muciniphila also excluded pregnant and lactating women from its target population. Without data for this group, talk to your obstetric clinician first.
How long does it take for Akkermansia to work?
The human trials of A. muciniphila ran for 12 weeks to about 6 months, and Pendulum's own consumer survey covered 12 weeks. There is no published timeline for Pendulum's single-strain capsule. If nothing you hoped for has changed after about 3 months of daily use, the trial evidence gives little reason to keep paying.
References
- Pendulum Therapeutics. Pendulum Akkermansia – Gut Health & Gut Lining Support Probiotic. Pendulum (manufacturer website), retrieved October 2026. 2026. Available at: https://pendulumlife.com/products/pendulum-akkermansia-probiotic-gut-health ↩
- Perraudeau F, McMurdie P, Bullard J, et al.. Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation. BMJ Open Diabetes Research & Care. 2020;8(1):e001319. doi:10.1136/bmjdrc-2020-001319 ↩
- Depommier C, Everard A, Druart C, et al.. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nature Medicine. 2019;25(7):1096-1103. doi:10.1038/s41591-019-0495-2 ↩
- Suenaert P, Segers A, Rymenans L, et al.. Effect of pasteurized Akkermansia muciniphila MucT on insulin sensitivity, body composition, and GLP-1 production in subjects with metabolic syndrome: impact of low baseline gut Akkermansia levels. Gut Microbes. 2026;18(1):2690689. doi:10.1080/19490976.2026.2690689 ↩
- Yu E, Eid J, Cheng A, Lynch B, Bauter M. Lack of genotoxicity and subchronic toxicity in safety assessment studies of Akkermansia muciniphila formulation. Toxicology Reports. 2024;13:101790. doi:10.1016/j.toxrep.2024.101790 ↩
- Zhang Y, Liu R, Chen Y, et al.. Akkermansia muciniphila supplementation in patients with overweight/obese type 2 diabetes: Efficacy depends on its baseline levels in the gut. Cell Metabolism. 2025;37(3):592-605.e6. doi:10.1016/j.cmet.2024.12.010 ↩
- EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck D, Bohn T, et al.. Safety of pasteurised Akkermansia muciniphila as a novel food pursuant to Regulation (EU) 2015/2283. EFSA Journal. 2021;19(9):e06780. doi:10.2903/j.efsa.2021.6780 ↩
- Mount S, Canfora EE, Jocken JW, et al.. Pasteurized Akkermansia muciniphila MucT for weight loss maintenance in people with overweight and obesity: a controlled randomized trial. Nature Medicine. 2026;32(6):2107-2116. doi:10.1038/s41591-026-04394-7 ↩
- Dao MC, Everard A, Aron-Wisnewsky J, et al.. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut. 2015;65(3):426-436. doi:10.1136/gutjnl-2014-308778 ↩
- Yoon HS, Cho CH, Yun MS, et al.. Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice. Nature Microbiology. 2021;6(5):563-573. doi:10.1038/s41564-021-00880-5 ↩
- US Food and Drug Administration. Information for Consumers on Using Dietary Supplements. US Food and Drug Administration. 2022. Available at: https://www.fda.gov/food/dietary-supplements/information-consumers-using-dietary-supplements ↩
- National Institutes of Health, Office of Dietary Supplements. Probiotics: Fact Sheet for Health Professionals. NIH Office of Dietary Supplements. 2026. Available at: https://ods.od.nih.gov/factsheets/Probiotics-HealthProfessional/ ↩
- Bonnema AL, Kolberg LW, Thomas W, Slavin JL. Gastrointestinal Tolerance of Chicory Inulin Products. Journal of the American Dietetic Association. 2010;110(6):865-868. doi:10.1016/j.jada.2010.03.025 ↩
- Chiantera V, Laganà AS, Basciani S, Nordio M, Bizzarri M. A Critical Perspective on the Supplementation of Akkermansia muciniphila: Benefits and Harms. Life. 2023;13(6):1247. doi:10.3390/life13061247 ↩
- Toh TS, Chong CW, Lim SY, et al.. Gut microbiome in Parkinson's disease: New insights from meta-analysis. Parkinsonism & Related Disorders. 2022;94:1-9. doi:10.1016/j.parkreldis.2021.11.017 ↩
- Cani PD, Depommier C, Derrien M, Everard A, de Vos WM. Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms. Nature Reviews Gastroenterology & Hepatology. 2022;19(10):625-637. doi:10.1038/s41575-022-00631-9 ↩
- de la Cuesta-Zuluaga J, Mueller NT, Corrales-Agudelo V, et al.. Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut. Diabetes Care. 2016;40(1):54-62. doi:10.2337/dc16-1324 ↩